Vitamin D regulates the tight-junction protein expression in active ulcerative colitis

Scandinavian Journal of Gastroenterology

Volumn 51, Issue 10, 2016, Pages 1193-1199

  Stio, Maria ^a   Retico, Luigina ^b   Annese, Vito ^b   Bonanomi, Andrea Giovanni ^b  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

Author keywords

Tight junctions proteins; ulcerative colitis; vitamin D

Indexed keywords

CALCITRIOL; CLAUDIN 1; CLAUDIN 2; CLAUDIN 4; CLAUDIN 7; INTERLEUKIN 13; INTERLEUKIN 6; MESALAZINE; STEROID; TIGHT JUNCTION PROTEIN; CLAUDIN; CLDN7 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN; VITAMIN D;

ADULT; ARTICLE; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTESTINE BIOPSY; MALE; MIDDLE AGED; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEROID THERAPY; ULCERATIVE COLITIS; BIOPSY; BLOOD; CELL CULTURE; DOWN REGULATION; EPITHELIUM CELL; INTESTINE MUCOSA; METABOLISM; PATHOLOGY; UPREGULATION;

ADULT; BIOPSY; CELLS, CULTURED; CLAUDIN-2; CLAUDIN-4; CLAUDINS; COLITIS, ULCERATIVE; DOWN-REGULATION; EPITHELIAL CELLS; FEMALE; HUMANS; INTERLEUKIN-13; INTERLEUKIN-6; INTESTINAL MUCOSA; MALE; MIDDLE AGED; UP-REGULATION; VITAMIN D;

EID: 84969837257     PISSN: 00365521     EISSN: 15027708     Source Type: Journal    
DOI: 10.1080/00365521.2016.1185463     Document Type: Article

References (32)

1. E.Ricart, R.Panaccione, E.V.LoftusJr,. Autoimmune disorders and extraintestinal manifestation in first-degree familial and sporadic inflammatory bowel disease: a case-control study. Inflamm Bowel Dis. 2004;10:207–214.
2. K.J.Maloy, F.Powrie Intestinal homeostasis and its breakdown in inflammatory bowel disease. Nature. 2011;474:298–306.
3. B.Khor, A.Gardet, R.J.Xavier Genetics and pathogenesis of inflammatory bowel disease. Nature. 2011;474:307–317.
4. S.Danese New therapies for inflammatory bowel disease: from the bench to the bedside. Gut. 2012;61:918–932.
5. T.Oshima, H.Miwa, T.Jon Changes in the expression of claudins in active ulcerative colitis. J Gastroenterol Hepatol. 2008;23:S146–S150.
6. S.V.Walsh, A.M.Hopkins, A.Nusrat. Modulation of tight junction structure and function by cytokines. Adv Drug Deliv Rev. 2000;41:303–313.
7. J.D.Schulzke, S.Ploeger, M.Amasheh,. Epithelial tight junctions in intestinal inflammation. Ann N Y Acad Sci. 2009;1165:294–300.
8. F.Heller, P.Florian, C.Boijarski,. Interleukin-13 is the key effector Th2 cytokine in ulcerative colitis that affects epithelial tight junctions, apoptosis, and cell restitution. Gastroenterology. 2005;129:550–564.
9. M.T.Cantorna, B.D.Mahon D-hormone and the immune system. J Rheumatol Suppl. 2005;76:11–20.
10. 3, and the immune system. Am J Clin Nutr. 2004;80:1717S–1720S.
11. V.P.Mouli, A.N.Ananthakrishnan. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014;39:125–136.
12. M.Garg, J.S.Lubel, M.P.Sparrow,. Review article: vitamin D and inflammatory bowel diseases - established concepts and future directions. Aliment Pharmacol Ther. 2012;36:324–344.
13. W.C.Lim, S.B.Hanaure, Y.C.Li Mechanisms of disease: vitamin D and inflammatory bowel diseases. Nat Clin Pract Gastroenterol Hepatol. 2005;2:308–315.
14. F.A.Farraye, H.Nimitphong, A.Stucchi,. Use of a novel vitamin D bioavailability test demonstrates that vitamin D absorption is decreased in patients with quiescent Crohn's disease. Inflamm Bowel Dis. 2011;17:2116–2121.
15. W.D.Leslie, N.Miller, L.Rogala,. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: The Manitoba IBD Cohort Study. Am J Gastroenterol. 2008;103:1451–1459.
16. G.Muzes, B.Molnar, Z.Tulassay,. Changes of the cytokine profile in inflammatory bowel diseases. World J Gastroenterol. 2012;18:5848–5861.
17. J.E.Lennard-Jones Classification of inflammatory bowel disease. Scand J Gastroenterol. 1989;24:2–6.
18. R.M.Feakins; British Society of Gastroenterology. Inflammatory bowel disease biopsies: updated British Society of Gastroenterology reporting guidelines. J Clin Pathol. 2013;66:1005–1026.
19. M.M.Bradford. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 1976;72:248–254.
20. U.K.Laemmli Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 1970;227:680–685.
21. S.Prasad, R.Mingrino, K.Kaukinen,. Inflammatory processes have differential effects on claudins 2, 3 and 4 in colonic epithelial cells. Lab Invest. 2005;85:1139–1162.
22. S.Amasheh, N.Meiri, A.H.Gitter,. Claudin-2 expression induces cation-selective channels in tight junctions of epithelial cells. J Cell Sci. 2002;115:4969–4976.
23. C.R.Weber, S.C.Nalle, M.Tretiakova,. Claudin-1 and claudin-2 expression is elevated in inflammatory bowel disease and may contribute to early neoplastic transformation. Lab Invest. 2008;88:1110–1120.
24. I.J.Fuss, F.Heller, M.Boirivant,. Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. J Clin Invest. 2004;113:1490–1497.
25. K.Kadivar, E.D.Ruchelli, J.E.Markowitz,. Intestinal interleukin-13 in pediatric inflammatory bowel disease patients. Inflamm Bowel Dis. 2004;10:593–598.
26. B.Vainer, O.H.Nielsen, J.Hendel,. Colonic expression and synthesis of interleukin 13 and interleukin 15 in inflammatory bowel disease. Cytokine. 2000;12:1531–1536.
27. P.Biancheri, A.Di Sabatino, F.Ammoscato,. Absence of a role for interleukin-13 in inflammatory bowel disease. Eur J Immunol. 2014;44:370–385.
28. D.Bernardo, S.Vallejo-Díez, E.R.Mann,. IL-6 promotes immune responses in human ulcerative colitis and induces a skin-homing phenotype in the dendritic cells and T cells they stimulate. Eur J Immunol. 2012 May;42:1337–1353.
29. J.Y.Zheng, D.Yu, M.Foroohar,. Regulation of the expression of the prostate-specific antigen by claudin-7. J Membr Biol. 2003;194:187–197.
30. M.Rutter, B.Saunders, K.Wilkinson,. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology. 2004;126:451–459.
31. J.Bornholdt, S.Friis, S.Godiksen,. The level of claudin-7 is reduced as an early event in colorectal carcinogenesis. BMC Cancer. 2011;11:65.
32. V.Hassan, S.Hassan, P.Seyed-Javad,. Association between Serum 25 (OH) vitamin D concentrations and inflammatory bowel diseases (IBDs) activity. Med J Malaysia. 2013;68:34–38.